Patents by Inventor Jeff Geesin

Jeff Geesin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
    Patent number: 8361467
    Abstract: The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-? synthesis; iii) an inhibitor of membrane-bound TNF-?; iv) an inhibitor of a natural receptor of TNF-?; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: January 29, 2013
    Assignee: DePuy Spine, Inc.
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Hassan Serhan, Martin A. Reynolds, Melissa Grace, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Gregory Collins, Laura J. Brown, Jeff Geesin, Pamela L. Plouhar, Catherine Smith, John Siekierka
  • Transdiscal administration of cycline compounds
    Publication number: 20050038001
    Abstract: The present invention relates to injecting a cycline compound into a diseased intervertebral disc.
    Type: Application
    Filed: August 13, 2003
    Publication date: February 17, 2005
    Applicant: DePuy Spine, Inc.
    Inventors: Mohamed Attawia, Thomas DiMauro, Hassan Serhan, Melissa Grace, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Gregory Collins, Laura Brown, Jeff Geesin, Pamela Plouhar, Catherine Smith, John Siekierka
  • Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
    Publication number: 20050025765
    Abstract: The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-? synthesis; iii) an inhibitor of membrane-bound TNF-?; iv) an inhibitor of a natural receptor of TNF-?; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.
    Type: Application
    Filed: July 30, 2003
    Publication date: February 3, 2005
    Applicant: DePuy Spine, Inc.
    Inventors: Thomas DiMauro, Mohamed Attawia, Hassan Serhan, Martin Reynolds, Melissa Grace, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Gregory Collins, Laura Brown, Jeff Geesin, Pamela Plouhar, Catherine Smith, John Siekierka
  • Transdiscal administration of specific inhibitors of P38 kinase
    Publication number: 20040229878
    Abstract: The present invention relates to injecting a high specificity p38 kinase inhibitor into a diseased intervertebral disc.
    Type: Application
    Filed: July 31, 2003
    Publication date: November 18, 2004
    Applicant: DePuy Spine, Inc.
    Inventors: Thomas M. DiMauro, Hassan Serhan, Mohamed Attawia, Melissa Grace, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Gregory Collins, Laura J. Brown, Jeff Geesin, Pamela L. Plouhar, Catherine Smith, John Siekierka